Novel strategies for the treatment of lung cancer: Modulation of eicosanoids

被引：4

作者：

Backlund, Michael G. ^{[1
,2
]}

Amann, Joseph M. ^{[1
,2
]}

Johnson, David H. ^{[1
,2
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37203 USA

[2] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Dept Canc Biol, Nashville, TN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 06期

关键词：

D O I：

10.1200/JCO.2007.14.9583

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：825 / 827

页数：3

相关论文

共 27 条

[1]

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: Sobering results [J].

Breathnach, OS ;

Freidlin, B ;

Conley, B ;

Green, MR ;

Johnson, DH ;

Gandara, DR ;

O'Connell, M ;

Shepherd, FA ;

Johnson, BE .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1734-1742

[2]

Cyclooxygenase as a target in lung cancer [J].

Brown, JR ;

DuBois, RN .

CLINICAL CANCER RESEARCH, 2004, 10 (12) :4266S-4269S

[3]

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 [J].

Chan, Andrew T. ;

Ogino, Shuji ;

Fuchs, Charles S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (21) :2131-2142

[4]

Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: A phase II trial of celecoxib and docetaxel [J].

Csiki, I ;

Morrow, JD ;

Sandler, A ;

Shyr, Y ;

Oates, J ;

Williams, MK ;

Dang, T ;

Carbone, DP ;

Johnson, DH .

CLINICAL CANCER RESEARCH, 2005, 11 (18) :6634-6640

[5]

NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer [J].

Ding, YF ;

Tong, M ;

Liu, SQ ;

Moscow, JA ;

Tai, HH .

CARCINOGENESIS, 2005, 26 (01) :65-72

[6]

Eicosanoid modulation in advanced lung cancer: Cyclooxygenase-2 expression is a positive predictive factor for celecoxib plus chemotherapy - Cancer and leukemia group B trial 30203 [J].

Edelman, Martin J. ;

Watson, Dee ;

Wang, Xiaofei ;

Morrison, Carl ;

Kratzke, Robert A. ;

Jewell, Scott ;

Hodgson, Lydia ;

Mauer, Ann M. ;

Gajra, Ajeet ;

Masters, Gregory A. ;

Bedor, Michelle ;

Vokes, Everett E. ;

Green, Mark J. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) :848-855

[7]

Targeting prostaglandin E EP receptors to inhibit metastasis [J].

Fulton, Amy M. ;

Ma, Xinrong ;

Kundu, Namita .

CANCER RESEARCH, 2006, 66 (20) :9794-9797

[8]

Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes [J].

Govindarajan, Rangaswamy ;

Ratnasinghe, Luke ;

Simmons, Debra L. ;

Siegel, Eric R. ;

Midathada, Madhu V. ;

Kim, Lawrence ;

Kim, Peter J. ;

Owens, Randall J. ;

Lang, Nicholas P. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) :1476-1481

[9]

Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase [J].

Hazra, Saswati ;

Batra, Raj K. ;

Tai, Hsin H. ;

Sharma, Sherven ;

Cui, Xiaoyan ;

Dubinett, Steven M. .

MOLECULAR PHARMACOLOGY, 2007, 71 (06) :1715-1720

[10]

Hida T, 1998, CANCER RES, V58, P3761